Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 7 of 7 entries
Sorted by: Best Match Show Resources per page
PRDX-1 supports the survival and antitumor activity of primary and CAR-modified NK cells under oxidative stress.

Cancer immunology research

Klopotowska M, Bajor M, Graczyk-Jarzynka A, Kraft A, Pilch Z, Zhylko A, Firczuk M, Baranowska I, Lazniewski M, Plewczynski D, Goral A, Soroczynska K, Domagała J, Marhelava K, Slusarczyk A, Retecki K, Ramji K, Krawczyk M, Temples MN, Sharma B, Lachota M, Netskar H, Malmberg KJ, Zagozdzon R, Winiarska M.
PMID: 34853030
Cancer Immunol Res. 2021 Dec 01; doi: 10.1158/2326-6066.CIR-20-1023. Epub 2021 Dec 01.

Oxidative stress, caused by the imbalance between reactive species generation and the dysfunctional capacity of antioxidant defenses, is one of the characteristic features of cancer. Here, we quantified hydrogen peroxide in the tumor microenvironment and demonstrated that hydrogen peroxide...

Cite
Klopotowska M, Bajor M, Graczyk-Jarzynka A, et al. PRDX-1 supports the survival and antitumor activity of primary and CAR-modified NK cells under oxidative stress. Cancer Immunol Res. 2021;doi: 10.1158/2326-6066.CIR-20-1023.
Klopotowska, M., Bajor, M., Graczyk-Jarzynka, A., Kraft, A., Pilch, Z., Zhylko, A., Firczuk, M., Baranowska, I., Lazniewski, M., Plewczynski, D., Goral, A., Soroczynska, K., Domagała, J., Marhelava, K., Slusarczyk, A., Retecki, K., Ramji, K., Krawczyk, M., Temples, M. N., Sharma, B., Lachota, M., Netskar, H., Malmberg, K. J., Zagozdzon, R., & Winiarska, M. (2021). PRDX-1 supports the survival and antitumor activity of primary and CAR-modified NK cells under oxidative stress. Cancer immunology research, . https://doi.org/10.1158/2326-6066.CIR-20-1023
Klopotowska, Marta, et al. "PRDX-1 supports the survival and antitumor activity of primary and CAR-modified NK cells under oxidative stress." Cancer immunology research vol. (2021). doi: https://doi.org/10.1158/2326-6066.CIR-20-1023
Klopotowska M, Bajor M, Graczyk-Jarzynka A, Kraft A, Pilch Z, Zhylko A, Firczuk M, Baranowska I, Lazniewski M, Plewczynski D, Goral A, Soroczynska K, Domagała J, Marhelava K, Slusarczyk A, Retecki K, Ramji K, Krawczyk M, Temples MN, Sharma B, Lachota M, Netskar H, Malmberg KJ, Zagozdzon R, Winiarska M. PRDX-1 supports the survival and antitumor activity of primary and CAR-modified NK cells under oxidative stress. Cancer Immunol Res. 2021 Dec 01; doi: 10.1158/2326-6066.CIR-20-1023. Epub 2021 Dec 01. PMID: 34853030.
Copy Download .nbib Format: NLM
The Tumor Microenvironment-A Metabolic Obstacle to NK Cells' Activity.

Cancers

Domagala J, Lachota M, Klopotowska M, Graczyk-Jarzynka A, Domagala A, Zhylko A, Soroczynska K, Winiarska M.
PMID: 33260925
Cancers (Basel). 2020 Nov 27;12(12). doi: 10.3390/cancers12123542.

NK cells have unique capabilities of recognition and destruction of tumor cells, without the requirement for prior immunization of the host. Maintaining tolerance to healthy cells makes them an attractive therapeutic tool for almost all types of cancer. Unfortunately,...

Cite
Domagala J, Lachota M, Klopotowska M, et al. The Tumor Microenvironment-A Metabolic Obstacle to NK Cells' Activity. Cancers (Basel). 2020;12(12)doi: 10.3390/cancers12123542.
Domagala, J., Lachota, M., Klopotowska, M., Graczyk-Jarzynka, A., Domagala, A., Zhylko, A., Soroczynska, K., & Winiarska, M. (2020). The Tumor Microenvironment-A Metabolic Obstacle to NK Cells' Activity. Cancers, 12(12), . https://doi.org/10.3390/cancers12123542
Domagala, Joanna, et al. "The Tumor Microenvironment-A Metabolic Obstacle to NK Cells' Activity." Cancers vol. 12,12 (2020). doi: https://doi.org/10.3390/cancers12123542
Domagala J, Lachota M, Klopotowska M, Graczyk-Jarzynka A, Domagala A, Zhylko A, Soroczynska K, Winiarska M. The Tumor Microenvironment-A Metabolic Obstacle to NK Cells' Activity. Cancers (Basel). 2020 Nov 27;12(12). doi: 10.3390/cancers12123542. PMID: 33260925; PMCID: PMC7761432.
Copy Download .nbib Format: NLM
PRDX-1 Supports the Survival and Antitumor Activity of Primary and CAR-Modified NK Cells under Oxidative Stress.

Cancer immunology research

Klopotowska M, Bajor M, Graczyk-Jarzynka A, Kraft A, Pilch Z, Zhylko A, Firczuk M, Baranowska I, Lazniewski M, Plewczynski D, Goral A, Soroczynska K, Domagala J, Marhelava K, Slusarczyk A, Retecki K, Ramji K, Krawczyk M, Temples MN, Sharma B, Lachota M, Netskar H, Malmberg KJ, Zagozdzon R, Winiarska M.
PMID: 34853030
Cancer Immunol Res. 2021 Dec 01; doi: 10.1158/2326-6066.CIR-20-1023. Epub 2021 Dec 01.

Oxidative stress, caused by the imbalance between reactive species generation and the dysfunctional capacity of antioxidant defenses, is one of the characteristic features of cancer. Here, we quantified hydrogen peroxide in the tumor microenvironment (TME) and demonstrated that hydrogen...

Cite
Klopotowska M, Bajor M, Graczyk-Jarzynka A, et al. PRDX-1 Supports the Survival and Antitumor Activity of Primary and CAR-Modified NK Cells under Oxidative Stress. Cancer Immunol Res. 2021;doi: 10.1158/2326-6066.CIR-20-1023.
Klopotowska, M., Bajor, M., Graczyk-Jarzynka, A., Kraft, A., Pilch, Z., Zhylko, A., Firczuk, M., Baranowska, I., Lazniewski, M., Plewczynski, D., Goral, A., Soroczynska, K., Domagala, J., Marhelava, K., Slusarczyk, A., Retecki, K., Ramji, K., Krawczyk, M., Temples, M. N., Sharma, B., Lachota, M., Netskar, H., Malmberg, K. J., Zagozdzon, R., & Winiarska, M. (2021). PRDX-1 Supports the Survival and Antitumor Activity of Primary and CAR-Modified NK Cells under Oxidative Stress. Cancer immunology research, . https://doi.org/10.1158/2326-6066.CIR-20-1023
Klopotowska, Marta, et al. "PRDX-1 Supports the Survival and Antitumor Activity of Primary and CAR-Modified NK Cells under Oxidative Stress." Cancer immunology research vol. (2021). doi: https://doi.org/10.1158/2326-6066.CIR-20-1023
Klopotowska M, Bajor M, Graczyk-Jarzynka A, Kraft A, Pilch Z, Zhylko A, Firczuk M, Baranowska I, Lazniewski M, Plewczynski D, Goral A, Soroczynska K, Domagala J, Marhelava K, Slusarczyk A, Retecki K, Ramji K, Krawczyk M, Temples MN, Sharma B, Lachota M, Netskar H, Malmberg KJ, Zagozdzon R, Winiarska M. PRDX-1 Supports the Survival and Antitumor Activity of Primary and CAR-Modified NK Cells under Oxidative Stress. Cancer Immunol Res. 2021 Dec 01; doi: 10.1158/2326-6066.CIR-20-1023. Epub 2021 Dec 01. PMID: 34853030.
Copy Download .nbib Format: NLM
Dynamics of Telomere Length and Telomerase Activity in the Human Fetal Liver at 5-12 Weeks of Gestation.

Stem cells international

Sorochynska K, Sych N, Duda A, Kulebyakina K, Krasnienkov D, Vaiserman A, Vatlitsov D.
PMID: 30057621
Stem Cells Int. 2018 Jul 02;2018:1385903. doi: 10.1155/2018/1385903. eCollection 2018.

Fetal stem cell- (FSC-) based therapy is a promising treatment option for many diseases. The differentiation potential of FSCs is greater than that in adult stem cells, and they are more tissue-specific and have lower immunogenicity and better intrinsic...

Cite
Sorochynska K, Sych N, Duda A, et al. Dynamics of Telomere Length and Telomerase Activity in the Human Fetal Liver at 5-12 Weeks of Gestation. Stem Cells Int. 2018;2018:1385903doi: 10.1155/2018/1385903.
Sorochynska, K., Sych, N., Duda, A., Kulebyakina, K., Krasnienkov, D., Vaiserman, A., & Vatlitsov, D. (2018). Dynamics of Telomere Length and Telomerase Activity in the Human Fetal Liver at 5-12 Weeks of Gestation. Stem cells international, 20181385903. https://doi.org/10.1155/2018/1385903
Sorochynska, Khrystyna, et al. "Dynamics of Telomere Length and Telomerase Activity in the Human Fetal Liver at 5-12 Weeks of Gestation." Stem cells international vol. 2018 (2018): 1385903. doi: https://doi.org/10.1155/2018/1385903
Sorochynska K, Sych N, Duda A, Kulebyakina K, Krasnienkov D, Vaiserman A, Vatlitsov D. Dynamics of Telomere Length and Telomerase Activity in the Human Fetal Liver at 5-12 Weeks of Gestation. Stem Cells Int. 2018 Jul 02;2018:1385903. doi: 10.1155/2018/1385903. eCollection 2018. PMID: 30057621; PMCID: PMC6051073.
Copy Download .nbib Format: NLM
Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries.

The British journal of ophthalmology

Fabian ID, Stacey AW, Foster A, Kivelä TT, Munier FL, Keren-Froim N, Gomel N, Cassoux N, Sagoo MS, Reddy MA, Harby LA, Zondervan M, Bascaran C, Abdallah E, Abdullahi SU, Boubacar SA, Ademola-Popoola DS, Adio A, Aghaji AE, Portabella SA, Alfa Bio AI, Ali AM, Alia DB, All-Eriksson C, Almeida AA, Alsawidi KM, Antonino R, Astbury NJ, Atsiaya R, Balaguer J, Balwierz W, Barranco H, Popovic MB, Benmiloud S, Guebessi NB, Berete RC, Biddulph SJ, Biewald EM, Blum S, Bobrova N, Boehme M, Bornfeld N, Bouda GC, Bouguila H, Boumedane A, Brichard BG, L MC, Castela G, Català-Mora J, Chantada GL, Chernodrinska VS, Chiwanga FS, Cieslik K, Comsa C, Correa Llano MG, Csóka M, Da Gama IV, Davidson A, Potter P, Desjardins L, Dragomir MD, Bruyn MD, Kettani AE, Elbahi AM, Elgalaly D, Elhaddad AM, Ali Elhassan MM, Elzembely MM, Essuman VA, Evina TGA, Fasina O, Fernández-Teijeiro A, Gandiwa M, Aldana DG, Geel JA, Gizachew Z, Gregersen PA, Guedenon KM, Hadjistilianou T, Hassan S, Hederova S, Hessissen L, Hordofa DF, Hummlen M, Husakova K, Ida R, Ilic VR, Jenkinson H, Amani Kabesha TB, Kabore RL, Kalinaki A, Kapelushnik N, Kardava T, Kemilev PK, Kepak T, Khotenashvili Z, Klett A, Kosh Komba Palet JE, Krivaitiene D, Kruger M, Kyara A, Lachmann ES, Latinović S, Lecuona K, Lukamba RM, Lumbroso L, Lysytsia L, Maka E, Makan M, Manda C, Begue NM, Matende IO, Matua M, Mayet I, Mbumba FB, Mengesha AA, Midena E, Mndeme FG, Mohamedani AA, Moll AC, Moreira C, Msina MS, Msukwa G, Muma KI, Murgoi G, Musa KO, Mustak H, Muyen OM, Naidu G, Naumenko L, Ndoye Roth PA, Neroev V, Nikitovic M, Nkanga ED, Nkumbe H, Nyaywa M, Obono-Obiang G, Oguego NC, Olechowski A, Oscar AH, Osei-Bonsu P, Painter SL, Paintsil V, Paiva L, Papyan R, Parrozzani R, Parulekar M, Pawinska-Wasikowska K, Perić S, Philbert R, Pochop P, Polyakov VG, Pompe MT, Pons JJ, Raobela L, Renner LA, Reynders D, Ribadu D, Riheia MM, Ritter-Sovinz P, Saakyan S, Said AM, Román Pacheco SS, Scanlan TA, Schoeman J, Seregard S, Sherief ST, Cheikh SS, Silva S, Sorochynska T, Ssali G, Stathopoulos C, Kranjc BS, Stones DK, Svojgr K, Sylla F, Tamamyan G, Tandili A, Tateshi B, Theophile T, Traoré F, Tyau-Tyau H, Umar AB, Urbak SF, Ushakova TL, Valeina S, Hoefen Wijsard MV, Veleva-Krasteva NV, Viksnins M, Wackernagel W, Waddell K, Wade PD, Wali Nigeria AH, Wime AD, Dod CW, Yanga JM, Yarovaya VA, Yarovoy AA, Zein E, Sharabi S, Zhilyaeva K, Ziko OA, Bowman R.
PMID: 32933936
Br J Ophthalmol. 2021 Oct;105(10):1435-1443. doi: 10.1136/bjophthalmol-2020-316613. Epub 2020 Sep 15.

BACKGROUND: The travel distance from home to a treatment centre, which may impact the stage at diagnosis, has not been investigated for retinoblastoma, the most common childhood eye cancer. We aimed to investigate the travel burden and its impact...

Cite
Fabian ID, Stacey AW, Foster A, et al. Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries. Br J Ophthalmol. 2020;105(10):1435-1443doi: 10.1136/bjophthalmol-2020-316613.
Fabian, I. D., Stacey, A. W., Foster, A., Kivelä, T. T., Munier, F. L., Keren-Froim, N., Gomel, N., Cassoux, N., Sagoo, M. S., Reddy, M. A., Harby, L. A., Zondervan, M., Bascaran, C., Abdallah, E., Abdullahi, S. U., Boubacar, S. A., Ademola-Popoola, D. S., Adio, A., Aghaji, A. E., Portabella, S. A., Alfa Bio, A. I., Ali, A. M., Alia, D. B., All-Eriksson, C., Almeida, A. A., Alsawidi, K. M., Antonino, R., Astbury, N. J., Atsiaya, R., Balaguer, J., Balwierz, W., Barranco, H., Popovic, M. B., Benmiloud, S., Guebessi, N. B., Berete, R. C., Biddulph, S. J., Biewald, E. M., Blum, S., Bobrova, N., Boehme, M., Bornfeld, N., Bouda, G. C., Bouguila, H., Boumedane, A., Brichard, B. G., L, M. C., Castela, G., Català-Mora, J., Chantada, G. L., Chernodrinska, V. S., Chiwanga, F. S., Cieslik, K., Comsa, C., Correa Llano, M. G., Csóka, M., Da Gama, I. V., Davidson, A., Potter, P., Desjardins, L., Dragomir, M. D., Bruyn, M. D., Kettani, A. E., Elbahi, A. M., Elgalaly, D., Elhaddad, A. M., Ali Elhassan, M. M., Elzembely, M. M., Essuman, V. A., Evina, T. G. A., Fasina, O., Fernández-Teijeiro, A., Gandiwa, M., Aldana, D. G., Geel, J. A., Gizachew, Z., Gregersen, P. A., Guedenon, K. M., Hadjistilianou, T., Hassan, S., Hederova, S., Hessissen, L., Hordofa, D. F., Hummlen, M., Husakova, K., Ida, R., Ilic, V. R., Jenkinson, H., Amani Kabesha, T. B., Kabore, R. L., Kalinaki, A., Kapelushnik, N., Kardava, T., Kemilev, P. K., Kepak, T., Khotenashvili, Z., Klett, A., Kosh Komba Palet, J. E., Krivaitiene, D., Kruger, M., Kyara, A., Lachmann, E. S., Latinović, S., Lecuona, K., Lukamba, R. M., Lumbroso, L., Lysytsia, L., Maka, E., Makan, M., Manda, C., Begue, N. M., Matende, I. O., Matua, M., Mayet, I., Mbumba, F. B., Mengesha, A. A., Midena, E., Mndeme, F. G., Mohamedani, A. A., Moll, A. C., Moreira, C., Msina, M. S., Msukwa, G., Muma, K. I., Murgoi, G., Musa, K. O., Mustak, H., Muyen, O. M., Naidu, G., Naumenko, L., Ndoye Roth, P. A., Neroev, V., Nikitovic, M., Nkanga, E. D., Nkumbe, H., Nyaywa, M., Obono-Obiang, G., Oguego, N. C., Olechowski, A., Oscar, A. H., Osei-Bonsu, P., Painter, S. L., Paintsil, V., Paiva, L., Papyan, R., Parrozzani, R., Parulekar, M., Pawinska-Wasikowska, K., Perić, S., Philbert, R., Pochop, P., Polyakov, V. G., Pompe, M. T., Pons, J. J., Raobela, L., Renner, L. A., Reynders, D., Ribadu, D., Riheia, M. M., Ritter-Sovinz, P., Saakyan, S., Said, A. M., Román Pacheco, S. S., Scanlan, T. A., Schoeman, J., Seregard, S., Sherief, S. T., Cheikh, S. S., Silva, S., Sorochynska, T., Ssali, G., Stathopoulos, C., Kranjc, B. S., Stones, D. K., Svojgr, K., Sylla, F., Tamamyan, G., Tandili, A., Tateshi, B., Theophile, T., Traoré, F., Tyau-Tyau, H., Umar, A. B., Urbak, S. F., Ushakova, T. L., Valeina, S., Hoefen Wijsard, M. V., Veleva-Krasteva, N. V., Viksnins, M., Wackernagel, W., Waddell, K., Wade, P. D., Wali Nigeria, A. H., Wime, A. D., Dod, C. W., Yanga, J. M., Yarovaya, V. A., Yarovoy, A. A., Zein, E., Sharabi, S., Zhilyaeva, K., Ziko, O. A., & Bowman, R. (2021). Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries. The British journal of ophthalmology, 105(10), 1435-1443. https://doi.org/10.1136/bjophthalmol-2020-316613
Fabian, Ido Didi, et al. "Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries." The British journal of ophthalmology vol. 105,10 (2021): 1435-1443. doi: https://doi.org/10.1136/bjophthalmol-2020-316613
Fabian ID, Stacey AW, Foster A, Kivelä TT, Munier FL, Keren-Froim N, Gomel N, Cassoux N, Sagoo MS, Reddy MA, Harby LA, Zondervan M, Bascaran C, Abdallah E, Abdullahi SU, Boubacar SA, Ademola-Popoola DS, Adio A, Aghaji AE, Portabella SA, Alfa Bio AI, Ali AM, Alia DB, All-Eriksson C, Almeida AA, Alsawidi KM, Antonino R, Astbury NJ, Atsiaya R, Balaguer J, Balwierz W, Barranco H, Popovic MB, Benmiloud S, Guebessi NB, Berete RC, Biddulph SJ, Biewald EM, Blum S, Bobrova N, Boehme M, Bornfeld N, Bouda GC, Bouguila H, Boumedane A, Brichard BG, L MC, Castela G, Català-Mora J, Chantada GL, Chernodrinska VS, Chiwanga FS, Cieslik K, Comsa C, Correa Llano MG, Csóka M, Da Gama IV, Davidson A, Potter P, Desjardins L, Dragomir MD, Bruyn MD, Kettani AE, Elbahi AM, Elgalaly D, Elhaddad AM, Ali Elhassan MM, Elzembely MM, Essuman VA, Evina TGA, Fasina O, Fernández-Teijeiro A, Gandiwa M, Aldana DG, Geel JA, Gizachew Z, Gregersen PA, Guedenon KM, Hadjistilianou T, Hassan S, Hederova S, Hessissen L, Hordofa DF, Hummlen M, Husakova K, Ida R, Ilic VR, Jenkinson H, Amani Kabesha TB, Kabore RL, Kalinaki A, Kapelushnik N, Kardava T, Kemilev PK, Kepak T, Khotenashvili Z, Klett A, Kosh Komba Palet JE, Krivaitiene D, Kruger M, Kyara A, Lachmann ES, Latinović S, Lecuona K, Lukamba RM, Lumbroso L, Lysytsia L, Maka E, Makan M, Manda C, Begue NM, Matende IO, Matua M, Mayet I, Mbumba FB, Mengesha AA, Midena E, Mndeme FG, Mohamedani AA, Moll AC, Moreira C, Msina MS, Msukwa G, Muma KI, Murgoi G, Musa KO, Mustak H, Muyen OM, Naidu G, Naumenko L, Ndoye Roth PA, Neroev V, Nikitovic M, Nkanga ED, Nkumbe H, Nyaywa M, Obono-Obiang G, Oguego NC, Olechowski A, Oscar AH, Osei-Bonsu P, Painter SL, Paintsil V, Paiva L, Papyan R, Parrozzani R, Parulekar M, Pawinska-Wasikowska K, Perić S, Philbert R, Pochop P, Polyakov VG, Pompe MT, Pons JJ, Raobela L, Renner LA, Reynders D, Ribadu D, Riheia MM, Ritter-Sovinz P, Saakyan S, Said AM, Román Pacheco SS, Scanlan TA, Schoeman J, Seregard S, Sherief ST, Cheikh SS, Silva S, Sorochynska T, Ssali G, Stathopoulos C, Kranjc BS, Stones DK, Svojgr K, Sylla F, Tamamyan G, Tandili A, Tateshi B, Theophile T, Traoré F, Tyau-Tyau H, Umar AB, Urbak SF, Ushakova TL, Valeina S, Hoefen Wijsard MV, Veleva-Krasteva NV, Viksnins M, Wackernagel W, Waddell K, Wade PD, Wali Nigeria AH, Wime AD, Dod CW, Yanga JM, Yarovaya VA, Yarovoy AA, Zein E, Sharabi S, Zhilyaeva K, Ziko OA, Bowman R. Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries. Br J Ophthalmol. 2021 Oct;105(10):1435-1443. doi: 10.1136/bjophthalmol-2020-316613. Epub 2020 Sep 15. PMID: 32933936.
Copy Download .nbib Format: NLM
Every-Other-Day Feeding Decreases Glycolytic and Mitochondrial Energy-Producing Potentials in the Brain and Liver of Young Mice.

Frontiers in physiology

Sorochynska OM, Bayliak MM, Gospodaryov DV, Vasylyk YV, Kuzniak OV, Pankiv TM, Garaschuk O, Storey KB, Lushchak VI.
PMID: 31824339
Front Physiol. 2019 Nov 22;10:1432. doi: 10.3389/fphys.2019.01432. eCollection 2019.

Intermittent fasting is used to reduce body mass in obese adult humans and animals. However, information on the impact of one type of intermittent fasting (IF) called every-other-day feeding (EODF) on young animals is scarce. In this study, 1-month-old...

Cite
Sorochynska OM, Bayliak MM, Gospodaryov DV, et al. Every-Other-Day Feeding Decreases Glycolytic and Mitochondrial Energy-Producing Potentials in the Brain and Liver of Young Mice. Front Physiol. 2019;10:1432doi: 10.3389/fphys.2019.01432.
Sorochynska, O. M., Bayliak, M. M., Gospodaryov, D. V., Vasylyk, Y. V., Kuzniak, O. V., Pankiv, T. M., Garaschuk, O., Storey, K. B., & Lushchak, V. I. (2019). Every-Other-Day Feeding Decreases Glycolytic and Mitochondrial Energy-Producing Potentials in the Brain and Liver of Young Mice. Frontiers in physiology, 101432. https://doi.org/10.3389/fphys.2019.01432
Sorochynska, Oksana M, et al. "Every-Other-Day Feeding Decreases Glycolytic and Mitochondrial Energy-Producing Potentials in the Brain and Liver of Young Mice." Frontiers in physiology vol. 10 (2019): 1432. doi: https://doi.org/10.3389/fphys.2019.01432
Sorochynska OM, Bayliak MM, Gospodaryov DV, Vasylyk YV, Kuzniak OV, Pankiv TM, Garaschuk O, Storey KB, Lushchak VI. Every-Other-Day Feeding Decreases Glycolytic and Mitochondrial Energy-Producing Potentials in the Brain and Liver of Young Mice. Front Physiol. 2019 Nov 22;10:1432. doi: 10.3389/fphys.2019.01432. eCollection 2019. PMID: 31824339; PMCID: PMC6883932.
Copy Download .nbib Format: NLM
Corrigendum: Every-Other-Day Feeding Decreases Glycolytic and Mitochondrial Energy-Producing Potentials in the Brain and Liver of Young Mice.

Frontiers in physiology

Sorochynska OM, Bayliak MM, Gospodaryov DV, Vasylyk YV, Kuzniak OV, Pankiv TM, Garaschuk O, Storey KB, Lushchak VI.
PMID: 32848836
Front Physiol. 2020 Jul 29;11:864. doi: 10.3389/fphys.2020.00864. eCollection 2020.

[This corrects the article DOI: 10.3389/fphys.2019.01432.].

Cite
Sorochynska OM, Bayliak MM, Gospodaryov DV, et al. Corrigendum: Every-Other-Day Feeding Decreases Glycolytic and Mitochondrial Energy-Producing Potentials in the Brain and Liver of Young Mice. Front Physiol. 2020;11:864doi: 10.3389/fphys.2020.00864.
Sorochynska, O. M., Bayliak, M. M., Gospodaryov, D. V., Vasylyk, Y. V., Kuzniak, O. V., Pankiv, T. M., Garaschuk, O., Storey, K. B., & Lushchak, V. I. (2020). Corrigendum: Every-Other-Day Feeding Decreases Glycolytic and Mitochondrial Energy-Producing Potentials in the Brain and Liver of Young Mice. Frontiers in physiology, 11864. https://doi.org/10.3389/fphys.2020.00864
Sorochynska, Oksana M, et al. "Corrigendum: Every-Other-Day Feeding Decreases Glycolytic and Mitochondrial Energy-Producing Potentials in the Brain and Liver of Young Mice." Frontiers in physiology vol. 11 (2020): 864. doi: https://doi.org/10.3389/fphys.2020.00864
Sorochynska OM, Bayliak MM, Gospodaryov DV, Vasylyk YV, Kuzniak OV, Pankiv TM, Garaschuk O, Storey KB, Lushchak VI. Corrigendum: Every-Other-Day Feeding Decreases Glycolytic and Mitochondrial Energy-Producing Potentials in the Brain and Liver of Young Mice. Front Physiol. 2020 Jul 29;11:864. doi: 10.3389/fphys.2020.00864. eCollection 2020. PMID: 32848836; PMCID: PMC7405638.
Copy Download .nbib Format: NLM
Showing 1 to 7 of 7 entries